The 6th Macrophage-Directed Therapies Summit 2024 covers topics such as:
- Unlocking Macrophages’ Full Potential: Leveraging Proof-of-Concept Data to Chart the Path for Better Patient Outcomes
- Illuminating the Boundless Potential of Macrophage-Directed Therapeutics Through Exploration of Novel Targets
- The Potential of Combination Therapies to Advance Efficacy & Safety
- Delving into Plasticity & Durability to Overcome Break Down Challenges Inherent to Working With Macrophages
- The Current Investment & Partnership Landscape to Equip Drug Developers with Insights to Secure Funding
- The Potential of Macrophages-Directed Therapies in Therapeutic Areas Beyond Oncology
- Novel Approaches that Promise to Pioneer the Next Generation of CAR-M Therapies
- Biomarker Development to Aid Patient Selection & Enhance Translatability
- Evaluating & Selecting the Most Effect Modes of Delivery & Administration for Your Pipeline to Ensure Targeted Treatment
The 6th Macrophage-Directed Therapies Summit 2024 brings together attendees from pharma, biotech and academic institutes.
